Our Studies

INVOcell Study

PREG is offering the opportunity to participate in a Clinical Study - Assessment of the INVOcell Intravaginal Culture System during 5-day (120 hours) vaginal incubation® 

Who MAY benefit?

Women seeking In Vitro Fertilization (IVF) treatment for infertility may benefit from this studyutilizing the INVOcell with IVF (IVF/IVC).

Study Objective:

The objective of this study is to assess the efficacy, comfort and retention of the INVOcell with theretention device, and demonstrate superiority following 5-day vaginal incubation as compared tocurrent 3-day vaginal incubation indication.

Women MAY qualify if they:

  • Are between the ages of 18 and 37
  • Have an anti-Müllerian hormone (AMH) level greater than or equal to 0.8 ng/mL
  • Had a normal uterine cavity as assessed in the past year by HSG, SHG or hysteroscopy.Prior tubal ligation is acceptable
  • This is not a full list. Additional inclusion criteria will apply.

Women May Not qualify if they have:

  • History of recurrent vaginitis or bacterial vaginosis or signs of current vaginal infection
  • Known allergies to plastic or silicone
  • BMI >36.0 kg/m2
  • Smoke tobacco or vape, or abuse drugs or alcohol
  • This is not a full list. Additional exclusion criteria will apply.

For more information please complete the screening questionnaire HERE.

PREG Ovulation Prediction Research Study

We are no longer accepting applicants for this study.